Format

Send to

Choose Destination
Pediatr Transplant. 2012 Mar;16(2):106-22. doi: 10.1111/j.1399-3046.2012.01644.x.

Current status of immunosuppressive agents for solid organ transplantation in children.

Author information

1
Paediatric Liver GI and Nutrition Centre, King's College Hospital, King's College London School of Medicine, London, UK.

Abstract

Immunosuppression after organ transplantation is complex and ever evolving. Over the past two decades, newer immunosuppressive agents have been introduced with an aim to provide better patient and graft survival. Improved therapeutic strategies have been developed offering the option to use combinations of drugs with non-overlapping toxicities. There are, however, only a few clinical studies with robust data to rationalize the use of these agents in children. This review will discuss the newer immunosuppressive agents used for solid organ transplant, their current status in post-transplant management and prevention of allograft rejection.

[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Wiley
Loading ...
Support Center